Clinical-Grade Validation of an Autofluorescence Virtual Staining System With Human Experts and a Deep Learning System for Prostate Cancer
Modern Pathology · 2024-11 · 37 (11) · 100573
DOI: 10.1016/j.modpat.2024.100573 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Modern Pathology, 2024-11. Verfasst von Pok Fai Wong und 17 weiteren Autor:innen. Beteiligte Einrichtung: Verily Life Sciences LLC, San Francisco, California. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Deep Learning, Neoplasm Grading. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
The tissue diagnosis of adenocarcinoma and intraductal carcinoma of the prostate includes Gleason grading of tumor morphology on the hematoxylin and eosin stain and immunohistochemistry markers on the prostatic intraepithelial neoplasia-4 stain (CK5/6, P63, and AMACR). In this work, we create an automated system for producing both virtual hematoxylin and eosin and prostatic intraepithelial neoplasia-4 immunohistochemistry stains from unstained prostate tissue using a high-throughput hyperspectral fluorescence microscope and artificial intelligence and machine learning. We demonstrate that the virtual stainer models can produce high-quality images suitable for diagnosis by genitourinary pathologists. Specifically, we validate our system through extensive human review and computational analysis, using a previously validated Gleason scoring model, and an expert panel, on a large data set of test slides. This study extends our previous work on virtual staining from autofluorescence, demonstrates the clinical utility of this technology for prostate cancer, and exemplifies a rigorous standard of qualitative and quantitative evaluation for digital pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Verily Life Sciences LLC, San Francisco, California.
- Verily Life Sciences LLC, San Francisco, California. Electronic address: cmcneil@verily.com.
- Verily Life Sciences LLC, San Francisco, California. Electronic address: wayang@verily.com.
- Google LLC, Mountain View, California.
- Leica Biosystems, Nussloch, Germany.
Zitieren
APA
Wong, P. F., McNeil, C., Wang, Y., Paparian, J., Santori, C., Gutierrez, M., Homyk, A., Nagpal, K., Jaroensri, T., Wulczyn, E., Yoshitake, T., Sigman, J., Steiner, D. F., Rao, S., Cameron Chen, P. H., Restorick, L., Roy, J., & Cimermancic, P. (2024). Clinical-Grade Validation of an Autofluorescence Virtual Staining System With Human Experts and a Deep Learning System for Prostate Cancer. Modern Pathology, 37(11), 100573. https://doi.org/10.1016/j.modpat.2024.100573
Vancouver
Wong PF, McNeil C, Wang Y, Paparian J, Santori C, Gutierrez M, et al. Clinical-Grade Validation of an Autofluorescence Virtual Staining System With Human Experts and a Deep Learning System for Prostate Cancer. Modern Pathology. 2024;37(11):100573. doi:10.1016/j.modpat.2024.100573
BibTeX
@article{Wong2024,
author = {Wong, Pok Fai and McNeil, Carson and Wang, Yang and Paparian, Jack and Santori, Charles and Gutierrez, Michael and Homyk, Andrew and Nagpal, Kunal and Jaroensri, Tiam and Wulczyn, Ellery and Yoshitake, Tadayuki and Sigman, Julia and Steiner, David F and Rao, Sudha and Cameron Chen, Po-Hsuan and Restorick, Luke and Roy, Jonathan and Cimermancic, Peter},
title = {Clinical-Grade Validation of an Autofluorescence Virtual Staining System With Human Experts and a Deep Learning System for Prostate Cancer},
journal = {Modern Pathology},
year = {2024},
volume = {37},
number = {11},
pages = {100573},
doi = {10.1016/j.modpat.2024.100573}
}
EUVIMED